News

RFK Jr. plans to phase out artificial food dyes in US
Health and Human Services Secretary Robert F. Kennedy Jr. will announce his plans to phase out artificial food dyes from the ...
Yahoo Finance4d
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
"Simplifying treatment by reducing the frequency of echo monitoring not only improves the patient ... allowing them to treat more patients." FDA-approved updates include reduced frequency of ...
Medical Xpress on MSN13d
Experimental drug NU-9 shows promise for Alzheimer's and ALS treatment
Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA ... "They collect junk and other components that are not useful to the cell, chew them up and ...
Prepared Foods6h
Federal Officials to Announce Plan to Remove Synthetic Food Dyes from US Supply
The move signals a significant shift in food policy that could impact product formulations across a wide range of categories, particularly those targeted toward children.
Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
A Phase 2 study evaluating TPST-1495 in patients with FAP is set to begin this year, conducted by the Cancer Prevention Clinical Trials Network and funded by the National Cancer Institute (NCI) ...
New York Post27d
FDA greenlights GSK’s drug for UTIs in women and girls
The Food and Drug Administration on Tuesday approved ... the US in the second half of the year, and did not disclose details on pricing. The FDA approved GSK’s drug for a common type of urinary ...
Food Safety News13d
Researchers say business user fees could ease budget woes at FDA and enhance food safety
A research team at New York University has come up with a way to fund FDA food programs, including food safety, without using ...
The Hill26d
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary ... if it occurs in a female individual who does not have a fever, is not pregnant, does not have a condition ...
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorderPlan to initiate ...
Morningstar4d
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
today announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS® (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules), simplifying treatment ...
Seeking Alpha4d
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
1,3 Additionally, CAMZYOS is no longer contraindicated with moderate CYP2C19 inhibitors and strong CYP3A4 inhibitors, which were adjusted to drug interactions. This provides physicians with ...